Literature DB >> 21244945

Integration of transmembrane signaling Cross-talk among G-protein-linked receptors and other signal transduction pathways.

J D Port1, C C Malbon.   

Abstract

The heart is a point of convergence for many transmembrane signal transduction pathways and, as such, exemplifies the complexities of sorting out their interactions. In the heart and cardiovascular system, hormone and neurotransmitter signals are propagated via G-protein-and non-G-protein-linked receptors. The receptors, in turn, are coupled to many effectors, including adenylylcyclases, phospholipases, and ion channels, as well as protein kinases and phosphatases. Integrating the information from numerous signaling pathways requires "cross-talk" among the different pathways. This article provides a perspective and attempts to describe in some detail what is known about a few of these interactions. Cross-talk from stimulatory to inhibitory adenylylcyclase pathways, from inhibitory to stimulatory adenylylcyclase pathways, from the adenylylcyclase to the phospholipase-C pathway, and from tyrosine kinase to G-protein-coupled receptors is described. Because of its central importance in the regulation of the cardiovascular system, and due to the availability of good model systems, the powerful responses mediated by the β-adrenergic receptor pathway serve as an excellent model to approach this subject.
Copyright © 1993. Published by Elsevier Inc.

Entities:  

Year:  1993        PMID: 21244945     DOI: 10.1016/1050-1738(93)90029-6

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  4 in total

Review 1.  An alternative perspective on ischemic preconditioning derived from mathematical modeling.

Authors:  P Whittaker
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

2.  Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning.

Authors:  A M Vogt; P Htun; M Arras; T Podzuweit; W Schaper
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

3.  Crosstalk between thrombin and adenylyl cyclase-stimulating agonists in proliferating human erythroid progenitor cells.

Authors:  H Porzig; R Gutknecht; K Thalmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

Review 4.  Deactivation of the sympathetic nervous system in patients with chronic congestive heart failure.

Authors:  E M Gilbert; J D Port
Journal:  Curr Cardiol Rep       Date:  2000-05       Impact factor: 3.955

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.